1.3000
09-May-25 16:45:00
15 minutes delayed
Stocks
-0.1700
-11.56%
Today's range
1.3000 - 1.5500
ISIN
N/A
Source
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 Jan 2025 07:00:00 By Nasdaq GlobeNewswire